Brain natriuretic peptide as a cardiac hormone in essential hypertension.
about
Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathwayN-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General PopulationEffect of valsartan on N-terminal pro-brain natriuretic Peptide in patient with stable chronic heart failure: comparison with enalaprilScreening for treatable left ventricular abnormalities in diabetic patients.Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP.Left ventricular dysfunction, natriuretic peptides, and mortality in an urban populationIncreasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosisValue of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese populationCan natriuretic peptides be used for the diagnosis of diastolic heart failure?Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failureEffects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failureRemodeling of the peripheral cardiac conduction system in response to pressure overloadAssociation of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart StudyBrain natriuretic peptide predicts mortality in the elderly.Suppression of Resting Metabolism by the Angiotensin AT2 Receptor.Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.Molecular forms of natriuretic peptides in heart failure and their implications.A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study.B-type natriuretic peptides in heart failure.Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.Brain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure.Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapy.Neuroendocrine activation after myocardial infarctionIntroducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only.Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus.Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke.Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures.Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study.Substantial intraindividual variability of BNP concentrations in patients with hypertension.Association of the brain natriuretic peptide gene with blood pressure and heart weight in the rat.N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration.Brain natriuretic peptide detects cardiac abnormalities in mass screening.Inappropriateness of ventricular hypertrophy is important as a determinant of BNP but not of diastolic filling in untreated hypertensive patients.Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy.Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension.Intraindividual temporal variance of biomarkers and the definition of individualized prognosis in cardiovascular patients.Practical implications of current natriuretic peptide research.The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis--one year follow-up.
P2860
Q34157188-681E6C3A-56C3-4D6F-81A5-35751A64C200Q34512556-EB192243-5788-487C-AAA7-BA1D8575208CQ34648756-D39A0362-446F-450A-A4E6-2836D61F06C1Q35116162-4C0604DE-2D39-41BC-B5AF-1E6F2E0D0FE2Q35375245-1210C03A-6F7F-4374-8623-E78CE2794196Q35380181-66528AAA-F80F-4D49-8D20-37F2A2779926Q35540503-798E9376-07BC-4140-AC7B-73016F8872F3Q35579682-6F8C68CA-0CF5-4D4F-B65A-AE78EACB1049Q35677306-BB64B87D-547B-4A33-9ED6-970F4AA0247DQ35771632-CF2EACF9-814D-4688-B7CD-5B07E5B0E143Q35772010-DE77EF7A-AEF9-49DA-96C9-68396EBD09F8Q35900985-4A66424B-61DB-4158-B330-46C3F96AE4D7Q36465512-538E23E2-92D1-4B4D-97B7-089CF2695A7BQ36841331-E49FB5A8-63D1-4314-92DD-F184B99D077AQ37168385-1F46AEC8-A3A1-40F1-8E43-E144C47DEFD7Q37399482-8E746910-DC5B-422F-8D95-74B3AEED565FQ37487209-B6CA422B-FEAF-4DD1-8E5B-D33A68D9B440Q37505066-6603F35D-0B22-43FD-97DB-E9ACC9C65D09Q37755096-F44E08FC-FA6E-4CD7-A538-68550C47537DQ38750251-199F6BDF-F0C3-4ADE-BA04-941A10CD4CDEQ40238774-5744A5F0-7480-4AB9-A968-3E853FC97A9AQ41036688-EA5B9BC1-8976-487F-8263-DD4CFD1FF651Q42578761-AC160A7B-5F93-4A13-99C0-AA34FB708C48Q43017128-879A1D50-BD27-4DCC-8B11-1452323351A2Q43923288-75B2260A-E3C4-464E-BA37-2BB0E2694281Q43956913-0063BBC4-A272-4857-AD88-A2DB1495E67FQ44664419-9BB67A54-D626-4724-8810-886FB8C91F53Q45329396-65B2BEF5-601E-4027-958F-D4727ECE325BQ46251869-7C814F41-85A4-4B77-9CF6-4D1F7D4594DEQ46950080-FE138FED-8ACD-4A8F-9A72-2A5EAC1C4698Q47308281-7803E094-C7D0-4393-8977-247AEE2EC550Q48153777-5A8F8351-AD46-4679-AAF0-401487DB56B5Q48230690-CA5DA586-9096-41A0-9921-690B4699173EQ48234513-EA2FAD27-5680-40A6-A403-D256E7502232Q48491794-0D441B7C-A278-4B48-AF72-111375DBA4CDQ48561403-91E7FF8D-2091-4474-95A1-820FC21ACAA5Q48581569-E7824E6A-EFC9-4AAE-95F6-9AB05870D1F0Q48614616-C0EF8882-7376-49CC-9EAC-EA30219A83ABQ48624965-10F9577F-B382-4D47-8565-F1A056D5C7E3Q48656360-614250BA-C546-4364-A9AC-BBE8B0336261
P2860
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@en
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@nl
type
label
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@en
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@nl
prefLabel
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@en
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@nl
P2093
P1476
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
@en
P2093
K Murakawa
K Takeuchi
K Yasunari
K Yokokawa
N Kurihara
P356
10.1016/0002-9343(92)90011-Y
P407
P577
1992-01-01T00:00:00Z